Objectives
- Establish interconnectivity and standardization among accredited DTLs/DTCs for data sharing with other agencies.
- Provide an efficient system for updating, maintaining, sharing, and accessing large volumes of repeated annual transaction data.
- Enforce standards on data input, processing, and output to simplify registration, verification, and monitoring.
- Produce accurate, reliable, and timely drug testing data.
- Improve client satisfaction via faster, more convenient, and more affordable public services.
- Strengthen quality assurance programs for DTLs/DTCs.
- Generate annual savings of at least PhP 1 billion in drug testing expenses.
Scope and Coverage
- Covers all Drug Test Laboratories and Centers under the Department of Health.
- Includes DOH’s Centers for Health Development (CHD) and Retained Hospitals.
- Extends to all Agency Data Beneficiaries who utilize drug test results.
General Guidelines
- Effective October 3, 2003, the DOH Information Management Service must deploy DTOMIS software to trained personnel in CHDs.
- DOH and CHDs shall also deploy DTOMIS software to all DOH-accredited DTLs/DTCs, including installation, training, distribution of materials, and drug test kit registration.
- Drug test results generated from DTOMIS are officially acceptable from October 3, 2003.
- From November 3, 2003, only drug test results generated via DTOMIS shall be accepted as official by DOH and all Agency Data Beneficiaries.
- Newly accredited DTLs/DTCs must coordinate with CHDs or DOH Central Office for DTOMIS installation and drug kit registration.
- DOH will transfer security codes for authenticating drug test results to heads of Agency Data Beneficiaries upon request.
- Agency Data Beneficiaries must protect the confidentiality of security codes and designate authorized personnel sworn to secrecy.
- Bureau of Health Facilities and Services and the Information Management Service will harmonize regulatory standards and ICT enhancements.
Agency Data Beneficiaries
- Comprise government agencies that are members of the Dangerous Drugs Board.
- Other entities may be designated by the DOH and the Dangerous Drugs Board as beneficiaries of the data.
Implementing Annexes
- Detailed implementing annexes available on the DOH DTOMIS website.
- Annexes include manuals, procedures for CHDs, drug test centers, information services, software use terms, and drug test kit registration procedures.
Repealing Clause
- Previous issuances conflicting with this Order are rescinded or modified to conform.
Separability Clause
- If any provision is declared invalid, the rest of the guidelines remain unaffected.
Effectivity
- The Order took effect immediately upon adoption on October 27, 2003 by Secretary of Health Manuel M. Dayrit, MD, MSc.